1. Home
  2. ATYR vs NREF Comparison

ATYR vs NREF Comparison

Compare ATYR & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • NREF
  • Stock Information
  • Founded
  • ATYR 2005
  • NREF 2019
  • Country
  • ATYR United States
  • NREF United States
  • Employees
  • ATYR N/A
  • NREF N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • NREF Real Estate Investment Trusts
  • Sector
  • ATYR Health Care
  • NREF Real Estate
  • Exchange
  • ATYR Nasdaq
  • NREF Nasdaq
  • Market Cap
  • ATYR 306.2M
  • NREF 246.0M
  • IPO Year
  • ATYR 2015
  • NREF 2020
  • Fundamental
  • Price
  • ATYR $5.25
  • NREF $13.99
  • Analyst Decision
  • ATYR Strong Buy
  • NREF Hold
  • Analyst Count
  • ATYR 6
  • NREF 3
  • Target Price
  • ATYR $20.20
  • NREF $14.50
  • AVG Volume (30 Days)
  • ATYR 3.5M
  • NREF 69.7K
  • Earning Date
  • ATYR 08-12-2025
  • NREF 07-31-2025
  • Dividend Yield
  • ATYR N/A
  • NREF 14.30%
  • EPS Growth
  • ATYR N/A
  • NREF N/A
  • EPS
  • ATYR N/A
  • NREF 2.59
  • Revenue
  • ATYR N/A
  • NREF $110,996,000.00
  • Revenue This Year
  • ATYR $960.85
  • NREF $25.18
  • Revenue Next Year
  • ATYR $1,283.47
  • NREF $3.65
  • P/E Ratio
  • ATYR N/A
  • NREF $5.41
  • Revenue Growth
  • ATYR N/A
  • NREF 370.78
  • 52 Week Low
  • ATYR $1.48
  • NREF $12.14
  • 52 Week High
  • ATYR $5.98
  • NREF $18.09
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 57.23
  • NREF 45.61
  • Support Level
  • ATYR $4.96
  • NREF $13.70
  • Resistance Level
  • ATYR $5.47
  • NREF $14.30
  • Average True Range (ATR)
  • ATYR 0.37
  • NREF 0.46
  • MACD
  • ATYR -0.07
  • NREF -0.01
  • Stochastic Oscillator
  • ATYR 61.11
  • NREF 38.23

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

Share on Social Networks: